✦ LIBER ✦

In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II

✍ Scribed by S. Konduri; M. A. Schwarz; R. E. Schwarz

Book ID: 110547679
Publisher: Springer
Year: 2004
Tongue: English
Weight: 333 KB
Volume: 11
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02524017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EMAP II-Based Antiangiogenic-Antiendothe

EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer

✍ Roderich E. Schwarz; Niranjan Awasthi; Srivani Konduri; Danielle Cafasso; Margar 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 690 KB

Combination Effects of Bortezomib with G

Combination Effects of Bortezomib with Gemcitabine and EMAP II in Experimental Pancreatic Cancer

✍ N. Awasthi; M.A. Schwarz; R.E. Schwarz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Effects of Combination of EMAP II with D

Effects of Combination of EMAP II with Doxorubicin, Docetaxel, Oxaliplatin and Gemcitabine to Enhance Antitumor Activity in Pancreatic Cancer

✍ N. Awasthi; M.A. Schwarz; R.E. Schwarz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Comparison of Gemcitabine Combined With

Comparison of Gemcitabine Combined With Targeted Agent Therapy Versus Gemcitabine Monotherapy in the Management of Advanced Pancreatic Cancer

✍ Li, Qin; Yuan, Zhenyan; Yan, Han; Wen, Zhaoyang; Zhang, Ruixue; Cao, Bangwei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 519 KB

6632 Characterisation of the response of

6632 Characterisation of the response of pancreatic cancer cells to treatment with chemotherapeutic agents alone and in combination with tyrosine kinase inhibitors

✍ Sheikh, R.; O'connor, R.; Walsh, N.; Clynes, M.; Mcdermott, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Gemcitabine in combination with 5-fluoro

Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer

✍ Helmut Oettle; Hanno Riess 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Pancreatic cancer is one of the most frequently reported gastrointestinal tumors and has been reported to have a 5-year survival rate of < 5%. It is most commonly diagnosed at an advanced stage and until recently, the most frequently administered treatment for patients with advanced disease has been